SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001325812-18-000020
Filing Date
2018-03-13
Accepted
2018-03-13 17:22:03
Documents
1
Period of Report
2018-03-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 7670
  Complete submission text file 0001325812-18-000020.txt   9148
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address BIOGEN INC LEGAL DEPARTMENT 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address
SHARP PHILIP A (Reporting) CIK: 0001226295 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36407 | Film No.: 18687441